Alvine Pharmaceuticals
Submit RFI/RFPAlvine is committed to developing biologics to target autoimmune/inflammatory diseases. Our initial focus targets celiac disease Celiac disease is a gluten-induced autoimmune disease for which no drug therapy is presently available.
Alvine was founded based on technology licensed from Stanford University. Alvine Pharmaceuticals is the leader in the discovery and development of biologics targeting celiac disease. Alvines primary goal is to translate new knowledge about immune system pathogenesis into innovative products that improve the lives of patients.
Read more at: http://www.alvinepharma.com/mission-value/
| Contact Address | 75 Shoreway Rd., Suite B San Carlos CA USA |
| Phone Number | (650) 632-1645 |
| info@alvinepharma.com | |
| Website | http://www.alvinepharma.com/ |
| Category | Value Based Care |
Listing ID: N/A
